1 Day
Source:
ناظورسيتي
ناظورسيتي
Ready to play
Ready to play
The Moroccan Agency for Drugs and Health Products has decided to suspend the marketing of six medicinal products manufactured by Novofarma Laboratory following the discovery of a non-compliance issue during an inspection. The affected products include Flostav, Torfa, Despamox, Roksam, Ajiderm, and Novofarma Iron. Pharmacies and distributors are required to stop selling these products, isolate the affected batches, and return the impacted shipments. This decision is part of measures to ensure the quality and safety of medicines before they reach consumers. The exact nature of the non-compliance detected has not yet been disclosed.
Notice: This Is an AI-Generated Summary
Comments (0)